Clinical Outcome of Parotid Gland Massage for Preventing Parotid Gland Dysfunction in Patients Treated with Radioiodine Therapy for Differentiated Thyroid Cancer: a Prospective Longitudinal Follow-Up Study
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Objectives: The aim of this study was to determine the clinical effectiveness of parotid gland(PG) massage for the prevention of PG dysfunction after administration of radioiodine (I-131) therapy fortreatment of differentiated thyroid cancer (DTC). Materials and Methods: One hundred patients with DTC withplanned high-dose I-131 therapy were enrolled in the clinical trial and randomized into two groups (massage andnon-massage group). Serum amylase values were obtained before and 24 h after I-131 therapy, and salivary glandscintigraphy (SGS) were taken before and at eight months after the I-131 therapy. Additional SGS (addSGS) weretaken when the patients complained symptoms related to salivary gland dysfunction. Questionnaire surveys wereperformed before and until two years after I-131 therapy. Results: Ninety-five of 100 patients finished the studyprotocol. Changes in survey scores tended to be higher in the non-massage group. The non-massage group hadmore severe symptoms related to salivary gland dysfunction. Among 32 patients who underwent addSGS, 27 hadnormal 8-month SGS. Of these 27 patients, 18 (66.7%) had salivary gland dysfunction on the addSGS. Amylasevalues were significantly increased in patients with normal 8-month SGS but abnormal addSGS, as compared topatients who were normal on both 8-month SGS and addSGS (p=0.046). Amylase difference values were asignificant predictor of abnormal addSGS (p=0.002). Conclusion: PG massage reduced symptoms related to salivarygland dysfunction. The PG massage may be helpful in preventing damage to salivary glands caused by I-131therapy.
Abstract
Background and Objectives: The aim of this study was to determine the clinical effectiveness of parotid gland(PG) massage for the prevention of PG dysfunction after administration of radioiodine (I-131) therapy fortreatment of differentiated thyroid cancer (DTC). Materials and Methods: One hundred patients with DTC withplanned high-dose I-131 therapy were enrolled in the clinical trial and randomized into two groups (massage andnon-massage group). Serum amylase values were obtained before and 24 h after I-131 therapy, and salivary glandscintigraphy (SGS) were taken before and at eight months after the I-131 therapy. Additional SGS (addSGS) weretaken when the patients complained symptoms related to salivary gland dysfunction. Questionnaire surveys wereperformed before and until two years after I-131 therapy. Results: Ninety-five of 100 patients finished the studyprotocol. Changes in survey scores tended to be higher in the non-massage group. The non-massage group hadmore severe symptoms related to salivary gland dysfunction. Among 32 patients who underwent addSGS, 27 hadnormal 8-month SGS. Of these 27 patients, 18 (66.7%) had salivary gland dysfunction on the addSGS. Amylasevalues were significantly increased in patients with normal 8-month SGS but abnormal addSGS, as compared topatients who were normal on both 8-month SGS and addSGS (p=0.046). Amylase difference values were asignificant predictor of abnormal addSGS (p=0.002). Conclusion: PG massage reduced symptoms related to salivarygland dysfunction. The PG massage may be helpful in preventing damage to salivary glands caused by I-131therapy.
참고문헌 (30)
- Ahn BC, "Personalized medicine based on theranostic radioiodine molecular imaging for differentiated thyroid cancer", Biomed Res Int, 2016, pp.1680464~ (2016)
- Hong CM, "Redifferentiation of radioiodine refractory differentiated thyroid cancer for reapplication of I-131 therapy", Front Endocrinol(Lausanne), 8, pp.260~ (2017)
- Hong CM, "I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer : comparison between recombinant human TSH administration and thyroid hormone withdrawal", Ann Nucl Med, 31(8), pp.582~589 (2017)
- Jeong JH, "Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in patients with intermediate-risk differentiated thyroid cancer", Nucl Med Commun, 38(3), pp.228~233 (2017)
- Alexander C, "Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma", J Nucl Med, 39(9), pp.1551~1554 (1998)
- Allweiss P, "Sialadenitis following I-131 therapy for thyroid carcinoma : concise communication", J Nucl Med, 25(7), pp.755~758 (1984)
- Kita T, "Multifactorial analysis on the short-term side effects occurring within 96 hours after radioiodine-131 therapy for differentiated thyroid carcinoma", Ann Nucl Med, 18(4), pp.345~349 (2004)
- Hong CM, "Emptying effect of massage on parotid gland radioiodine content", Nucl Med Commun, 35(11), pp.1127~1131 (2014)
- Kim HW, "Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake", Thyroid, 22(6), pp.611~616 (2012)
- Son SH, "The preventive effect of parotid gland massage on salivary gland dysfunction during high-dose radioactive iodine therapy for differentiated thyroid cancer : a randomized clinical trial", Clin Nucl Med, 44(8), pp.625~633 (2019)
- Becciolini A, "Plasma amylase activity as a biochemical indicator of radiation injury to salivary glands", Acta Radiol Oncol, 23(1), pp.9~14 (1984)
- Kishima HK, "Post-irradiation sialadenitis. A study of the clinical features, histopathologic changes and serum enzyme variations following irradiation of human salivary glands", Am J Roentgenol Radium Therapy Nucl Med, 94, pp.271~291 (1965)
- Van den Brenk HA, "Serum amylase as a measure of salivary gland radiation damage. Hyperamylasaemia following fractionated exposure to 4 MV X rays delivered in high pressure oxygen, and effects of certain steroids on this response", Br J Radiol, 42(501), pp.688~700 (1969)
- Eisbruch A, "Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer", Int J Radiat Oncol Biol Phys, 50(3), pp.695~704 (2001)
- Ahn BC, "Sodium iodide symporter for nuclear molecular imaging and gene therapy : from bedside to bench and back", Theranostics, 2(4), pp.392~402 (2012)
- De La Vieja A, "Molecular analysis of the sodium", iodide symporter : impact on thyroid and extrathyroid pathophysiology, 2000, pp.80(3), 1083~1105
- Mandel SJ, "Radioactive iodine and the salivary glands", Thyroid, 13(3), pp.265~271 (2003)
- Oh JR, "False-positive uptake on radioiodine wholebody scintigraphy : physiologic and pathologic variants unrelated to thyroid cancer", Am J Nucl Med Mol Imaging, 2(3), pp.362~385 (2012)
- Hall EJ, "Radiobiology for the radiologist" (2000), Lippincott Williams & Wilkins
- Van Nostrand D, "Sialoadenitis secondary to(1)(3)(1)I therapy for well-differentiated thyroid cancer", Oral Dis, 17(2), pp.154~161 (2011)
- Fox PC, "Acquired salivary dysfunction. Drugs and radiation", Ann N Y Acad Sci, 842, pp.132~137 (1998)
- van Luijk P, "Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer", Sci Transl Med, 7(305) (2015)[DOI]
- Klein Hesselink EN, "Radioiodine treatment and thyroid hormone suppression therapy for differentiated thyroid carcinoma : adverse effects support the trend toward less aggressive treatment for low-risk patients", Eur Thyroid J, 4(2), pp.82~92 (2015)
- Jeong SY, "Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer : direct comparison of pre-and postablation scintigraphies and their relation to xerostomia symptoms", Thyroid, 23(5), pp.609~616 (2013)
- Hancock PJ, "Oral and dental management related to radiation therapy for head and neck cancer", J Can Dent Assoc, 69(9), pp.585~590 (2003)
- Cady J, "Nutritional support during radiotherapy for head and neck cancer : the role of prophylactic feeding tube placement", Clin J Oncol Nurs, 11(6), pp.875~880 (2007)
- Li Y, "The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy", Int J Radiat Oncol Biol Phys, 67(3), pp.660~669 (2007)
- Stephens LC, "Acute and late radiation injury in rhesus monkey parotid glands. Evidence of interphase cell death", Am J Pathol, 124(3), pp.469~478 (1986)
- Marmary Y, "Radiation-induced loss of salivary gland function is driven by cellular senescence and prevented by IL6 modulation", Cancer Res, 76(5), pp.1170~1180 (2016)
- Pawlikowski JS, "Senescence at a glance", J Cell Sci, 126(Pt 18), pp.4061~4067 (2013)